144 related articles for article (PubMed ID: 36386036)
1. Cost-effectiveness of childhood cancer treatment in Egypt: Lessons to promote high-value care in a resource-limited setting based on real-world evidence.
Soliman R; Oke J; Sidhom I; Bhakta N; Bolous NS; Tarek N; Ahmed S; Abdelrahman H; Moussa E; Zamzam M; Fawzy M; Zekri W; Hafez H; Sedky M; Hammad M; Elzomor H; Ahmed S; Awad M; Abdelhameed S; Mohsen E; Shalaby L; Eweida W; Abouelnaga S; Elhaddad A; Heneghan C
EClinicalMedicine; 2023 Jan; 55():101729. PubMed ID: 36386036
[TBL] [Abstract][Full Text] [Related]
2. Cost and cost-effectiveness of childhood cancer treatment in low-income and middle-income countries: a systematic review.
Fung A; Horton S; Zabih V; Denburg A; Gupta S
BMJ Glob Health; 2019; 4(5):e001825. PubMed ID: 31749998
[TBL] [Abstract][Full Text] [Related]
3. The cost effectiveness of treating Burkitt lymphoma in Uganda.
Denburg AE; Laher N; Mutyaba I; McGoldrick S; Kambugu J; Sessle E; Orem J; Casper C
Cancer; 2019 Jun; 125(11):1918-1928. PubMed ID: 30840316
[TBL] [Abstract][Full Text] [Related]
4. Cost per DALY averted in low, middle- and high-income countries: evidence from the global burden of disease study to estimate the cost-effectiveness thresholds.
Daroudi R; Akbari Sari A; Nahvijou A; Faramarzi A
Cost Eff Resour Alloc; 2021 Feb; 19(1):7. PubMed ID: 33541364
[TBL] [Abstract][Full Text] [Related]
5. Childhood cancer hospital resource utilization and costs in Egypt, 2013-2017; patterns, trends, and associated factors for 8886 patients from Children's Cancer Hospital, Egypt.
Soliman R; Elhaddad A; Oke J; Eweida W; Tarek N; Hamza M; Yang Y; Abouelnaga S; Heneghan C
Pediatr Blood Cancer; 2021 Nov; 68(11):e29347. PubMed ID: 34520099
[TBL] [Abstract][Full Text] [Related]
6. Estimating a cost-effectiveness threshold for health care decision-making in South Africa.
Edoka IP; Stacey NK
Health Policy Plan; 2020 Jun; 35(5):546-555. PubMed ID: 32125375
[TBL] [Abstract][Full Text] [Related]
7. The cost effectiveness of treating paediatric cancer in low-income and middle-income countries: a case-study approach using acute lymphocytic leukaemia in Brazil and Burkitt lymphoma in Malawi.
Bhakta N; Martiniuk AL; Gupta S; Howard SC
Arch Dis Child; 2013 Feb; 98(2):155-60. PubMed ID: 23201550
[TBL] [Abstract][Full Text] [Related]
8. Cost Effectiveness of Implementing Integrated Management of Neonatal and Childhood Illnesses Program in District Faridabad, India.
Prinja S; Bahuguna P; Mohan P; Mazumder S; Taneja S; Bhandari N; van den Hombergh H; Kumar R
PLoS One; 2016; 11(1):e0145043. PubMed ID: 26727369
[TBL] [Abstract][Full Text] [Related]
9. Determining the cost and cost-effectiveness of childhood cancer treatment in Haiti.
Bolous NS; Mercredi P; Bonilla M; Friedrich P; Bhakta N; Metzger ML; Gassant PY
Ecancermedicalscience; 2024; 18():1675. PubMed ID: 38439808
[TBL] [Abstract][Full Text] [Related]
10. Comparison of best supportive care, CHOP, or R-CHOP for treatment of diffuse large B-cell lymphoma in Malawi: a cost-effectiveness analysis.
Painschab MS; Kohler R; Kimani S; Mhango W; Kaimila B; Zuze T; Mithi V; Kasonkanji E; Mumba N; Nyasosela R; Wheeler S; Gopal S
Lancet Glob Health; 2021 Sep; 9(9):e1305-e1313. PubMed ID: 34303416
[TBL] [Abstract][Full Text] [Related]
11. Cost-effectiveness of running a paediatric oncology unit in Ethiopia.
Kiros M; Memirie ST; Tolla MTT; Palm MT; Hailu D; Norheim OF
BMJ Open; 2023 Mar; 13(3):e068210. PubMed ID: 36918241
[TBL] [Abstract][Full Text] [Related]
12. Temporal trends in childhood cancer survival in Egypt, 2007 to 2017: A large retrospective study of 14 808 children with cancer from the Children's Cancer Hospital Egypt.
Soliman RM; Elhaddad A; Oke J; Eweida W; Sidhom I; Ahmed S; Abdelrahman H; Moussa E; Fawzy M; Zamzam M; Zekri W; Hafez H; Sedky M; Abdalla A; Hammad M; Elzomor H; Ahmed S; Awad M; Abdelhameed S; Mohsen E; Shalaby L; Fouad H; Tarek N; Abouelnaga S; Heneghan C
Int J Cancer; 2021 Apr; 148(7):1562-1574. PubMed ID: 32997796
[TBL] [Abstract][Full Text] [Related]
13. Prevention of violence against women and girls: A cost-effectiveness study across 6 low- and middle-income countries.
Ferrari G; Torres-Rueda S; Chirwa E; Gibbs A; Orangi S; Barasa E; Tawiah T; Dwommoh Prah RK; Hitimana R; Daviaud E; Kapapa E; Dunkle K; Heise L; Stern E; Chatterji S; Omondi B; Ogum Alangea D; Karmaliani R; Maqbool Ahmed Khuwaja H; Jewkes R; Watts C; Vassall A
PLoS Med; 2022 Mar; 19(3):e1003827. PubMed ID: 35324910
[TBL] [Abstract][Full Text] [Related]
14. Cost and Cost-Effectiveness of Treating Childhood Cancer at Jimma Medical Center.
Genemo I; Chala TK; Hordofa DF; Sinkie SO
Clinicoecon Outcomes Res; 2023; 15():433-442. PubMed ID: 37309357
[TBL] [Abstract][Full Text] [Related]
15. Barriers and Facilitators to Implementing Cost-Effective Evidence-Based Childhood Cancer Treatment in a Resource-Limited Setting in Egypt: A Qualitative Interview Study.
Soliman R; Heneghan C; Boylan AM; Oke J; Eweida W; Elhaddad A
JCO Glob Oncol; 2023 Jun; 9():e2200424. PubMed ID: 37290021
[TBL] [Abstract][Full Text] [Related]
16. An overview of childhood cancer care and outcomes in Egypt: a narrative review.
Soliman R; Bolous N; Heneghan C; Oke J; Boylan AM; Eweida W; Abouelnaga S; Elhaddad A
Ecancermedicalscience; 2024; 18():1676. PubMed ID: 38439811
[TBL] [Abstract][Full Text] [Related]
17. Comparative value-based pricing of an Ebola vaccine in resource-constrained countries based on cost-effectiveness analysis.
Obeng-Kusi M; Erstad B; Roe DJ; Abraham I
J Med Econ; 2022; 25(1):894-902. PubMed ID: 35748085
[TBL] [Abstract][Full Text] [Related]
18. A cost-effectiveness analysis of a program to control rheumatic fever and rheumatic heart disease in Pinar del Rio, Cuba.
Watkins DA; Mvundura M; Nordet P; Mayosi BM
PLoS One; 2015; 10(3):e0121363. PubMed ID: 25768008
[TBL] [Abstract][Full Text] [Related]
19. Health benefits, costs, and cost-effectiveness of earlier eligibility for adult antiretroviral therapy and expanded treatment coverage: a combined analysis of 12 mathematical models.
Eaton JW; Menzies NA; Stover J; Cambiano V; Chindelevitch L; Cori A; Hontelez JA; Humair S; Kerr CC; Klein DJ; Mishra S; Mitchell KM; Nichols BE; Vickerman P; Bakker R; Bärnighausen T; Bershteyn A; Bloom DE; Boily MC; Chang ST; Cohen T; Dodd PJ; Fraser C; Gopalappa C; Lundgren J; Martin NK; Mikkelsen E; Mountain E; Pham QD; Pickles M; Phillips A; Platt L; Pretorius C; Prudden HJ; Salomon JA; van de Vijver DA; de Vlas SJ; Wagner BG; White RG; Wilson DP; Zhang L; Blandford J; Meyer-Rath G; Remme M; Revill P; Sangrujee N; Terris-Prestholt F; Doherty M; Shaffer N; Easterbrook PJ; Hirnschall G; Hallett TB
Lancet Glob Health; 2014 Jan; 2(1):e23-34. PubMed ID: 25104632
[TBL] [Abstract][Full Text] [Related]
20. Cost-effectiveness of a combined intervention of long lasting insecticidal nets and indoor residual spraying compared with each intervention alone for malaria prevention in Ethiopia.
Hailu A; Lindtjørn B; Deressa W; Gari T; Loha E; Robberstad B
Cost Eff Resour Alloc; 2018; 16():61. PubMed ID: 30498400
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
